A discordant, falsely low free light chains, type lambda (flc lambda) result was obtained on a patient sample using a 1:20 dilution on an atellica neph 630 system using n latex flc lambda reagent.The discordant result was reported to the physician(s) and was questioned by the physician(s).The same sample was repeated for flc lambda on a non-siemens system using a non-siemens reagent, recovering higher.The result from the non-siemens system was reported, as the correct result, to the physician(s).The sample was repeated again for flc lambda five days later using a 1:20 dilution on the same atellica neph 630 system using n latex flc lambda reagent, recovering low.The following day, the sample was repeated three more times for flc lambda, twice using a 1:20 dilution and once using a 1:5 dilution, recovering low.These repeat results were not reported to the physician(s).There are no known reports of patient intervention or adverse health consequences due to the discordant, falsely low flc lambda results.
|
Siemens filed the initial mdr 9610806-2021-00045 on 21-may-2021.Additional information (15-jun-2021): additional investigation determined that quality controls (qc) were run using the n latex flc lambda reagent and recovered in range.The affected sample was analyzed on the size exclusion column (sec) and bound light chains in immunoglobulin a-lambda (iga-lambda) were separated from free light chains, type lambda (flc lambda).The low flc lambda result in this sample was not related to the presence of high levels of iga.It was determined that the falsely low results with this particular sample were not related to a malfunction of the n latex flc lambda assay, but more related to a sample specific issue, whereby the cause of the event is unknown.The reagent is performing according to specifications.No further evaluation of this device is required.Mdrs 9610806-2021-00046_s1 and 9610806-2021-00047_s1 were also filed for the additional information obtained on 15-jun-2021.
|